Observational studyRMD open2023

Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study.

Liselotte Tidblad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.